These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9375024)

  • 1. 3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.
    Becciolini A; Balzi M; Barbarisi M; Faraoni P; Biggeri A; Potten CS
    Cell Prolif; 1997; 30(3-4):117-26. PubMed ID: 9375024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labeling index in squamous cell carcinoma of the larynx.
    Balzi M; Ninu BM; Becciolini A; Scubla E; Boanini P; Gallina E; Gallo O; Fini-Storchi O; Bondi R
    Head Neck; 1991; 13(4):344-8. PubMed ID: 1869437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic cell proliferation in normal mucosa of patients with colon cancer.
    Becciolini A; Balzi M; Faraoni P; Tisti E; Zappoli Thyrion G; Giachè V; Bandettini L; Potten CS
    Acta Oncol; 1998; 37(1):65-71. PubMed ID: 9572656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro thymidine labelling of human pulmonary neoplasms.
    Kerr KM; Robertson AM; Lamb D
    Br J Cancer; 1983 Feb; 47(2):245-52. PubMed ID: 6824569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
    Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
    Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
    Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity in normal colon mucosa and tumor tissue: clinical implications.
    Balzi M; Becciolini A; Mauri P; Larosa V; Bechi P
    In Vivo; 1993; 7(6B):635-7. PubMed ID: 8193286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.
    Meyer JS; Wittliff JL
    Int J Cancer; 1991 Jan; 47(2):213-20. PubMed ID: 1988366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic pattern of human urinary transitional cell carcinoma.
    Lavezzi AM; Costa A; Milesi M; Matturri L
    Basic Appl Histochem; 1986; 30(2):239-42. PubMed ID: 3741320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic significance of thymidine labelling index in primary breast cancer.
    Cooke TG; Stanton PD; Winstanley J; Murray GD; Croton R; Holt S; George WD
    Eur J Cancer; 1992; 28(2-3):424-6. PubMed ID: 1591056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
    Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
    Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine labeling index: prognostic role in breast cancer.
    Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
    Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.
    Maurer-Schultze B; Bassukas ID; Böswald M; Harasim M
    J Cancer Res Clin Oncol; 1992; 118(4):255-68. PubMed ID: 1577846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer. The SICCAB Group for Quality Control of Cell Kinetic Determination.
    Silvestrini R
    Cell Prolif; 1991 Sep; 24(5):437-45. PubMed ID: 1932355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissues.
    Bleiberg H; Morret M; Galand P
    Eur J Cancer; 1993; 29A(3):400-3. PubMed ID: 8104445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers.
    Ponz de Leon M; Costa A; Lanza G; Scalmati A; Roncucci L; Faranda A; Di Gregorio C; Fante R; Colella G; Silvestrini R
    Mod Pathol; 1991 Sep; 4(5):627-31. PubMed ID: 1758875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
    Kamel OW; Franklin WA; Ringus JC; Meyer JS
    Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitotic cell divisions and tumour growth: an alternative model for cell kinetic compartments in solid tumours.
    Bhattathiri VN
    Oral Oncol; 2001 Apr; 37(3):288-95. PubMed ID: 11287284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.
    Barbieri F; Parodi G; Massa T; Cagnoli M; Barbi G; Imperiale A; Alama A
    Anticancer Res; 1994; 14(5A):1973-7. PubMed ID: 7847836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.